ACS chemical neuroscience molecule spotlight on gilenya (fingolimod; FTY720).
Department of Pharmacology and Vanderbilt Program in Drug Discovery, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee 37232-6600, United States.
Corey R
CR
Hopkins
D000818:Animals; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D009488:Neurosciences / Q000639:trends; D011409:Propylene Glycols / Q000737:chemistry / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012958:Societies, Scientific; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine